avatar

ANDRI SANITYOSO SULAIMAN

Universitas Indonesia Sp-2 - Ilmu Penyakit Dalam SINTA ID : 6748895
983
SINTA Score Overall
257
SINTA Score 3Yr
983
Affil Score
257
Affil Score 3Yr
Latest number of activities
COMPARISON OF HBSAG NEXT ARCHITECT®, HBSAG QUALITATIVE II, AND HBSAG DETERMINE 2 AS MARKERS FOR STARTING AND STOPPING RULE FOR THE TREATMENT OF CHRONIC HEPATITIS B
Leader : Andri Sanityoso Sulaiman KOMPETITIF ( PUTI Q1 2024 )
Personils : -
2024 Rp. 150.000.000 Approved INTERNAL SOURCE
COMPARISON OF EFFICACY AND SAFETY OF SOFOSBUVIR/DACLATASVIR WITH GRAZOPREVIR/ELBASVIR IN CHRONIC HEPATITIS C PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS
Leader : Andri Sanityoso Sulaiman PUTI Q2 2023 ( PUTI Q2 2023 )
Personils : -
2023 Rp. 99.480.000 Approved INTERNAL SOURCE
View more ...
Get More with SINTA Insight
Go to Insight

Summary

Article Quartile
Research Output
  Scopus GScholar WOS
Article 44 39 0
Citation 604 293 0
Cited Document 37 21 0
H-Index 13 10
i10-Index 16 10
G-Index 3 2
Get More with SINTA Insight

Go to Insight